Now that there is an approved therapy for seborrheic dermatitis, it is time to give this condition the attention and respect ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

Atopic dermatitis, a chronic skin condition, is common in children and requires treatment to minimise frequent flares. Dr Ker ...

Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

异位性皮肤炎不仅会伤害患者的皮肤，也可能影响生活质量和日常活动。新加坡中央医院将在9月13日（星期五）举办“异位性皮肤炎——不止是皮肤表层问题”（Atopic Dermatitis – More than skin deep?）线上英语讲座。

The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...

中国网9月14日讯（记者王一辰）9 月 14 日是第七个的“世界特应性皮炎日” (World Atopic Dermatitis ...

Dupilumab decreases general and type 2 inflammatory biomarker levels in children with moderate to severe atopic dermatitis.

The Food and Drug Administration (FDA) has approved Ebglyss™ (lebrikizumab-lbkz) for the treatment of adult and pediatric ...

Elanco Animal Health Inc. (ELAN) announced the U.S. Food and Drug Administration has approved Zenrelia, a convenient once-daily oral ...